Better Buy: Exact Sciences vs. Illumina
Some early investors have gotten rich from the genomics revolution. The stocks of two of the top companies in the genomics arena, Exact Sciences (NASDAQ: EXAS) and Illumina (NASDAQ: ILMN), have delivered returns of more than 2,800% and 780%, respectively, over the last 10 years.
Both of these stocks could continue to generate significant gains, but which is the better pick for long-term investors? Here's how Exact Sciences and Illumina stack up against each other.
Image source: Getty Images.
Source Fool.com